In a standard biopsy, tissue samples are taken randomly from the prostate and evaluated by pathology. This approach can miss almost half of all cancers.
With ClariCore, a needle is inserted and, before tissue samples are taken, spectroscopy is performed. Integrated fiber optics shine light of specific wavelengths into the tissue.
The returned light is instantaneously analyzed by a spectrometer and an AI algorithm, classifying the tissue as benign or suspicious. This has the potential to find more cancers.